product:wellbutrin

GlaxoSmithKline pays out £63m to settle US marketing allegations | World news | The Guardian
▻http://www.theguardian.com/world/2014/jun/04/glaxosmithkline-settle-lawsuit

The company was accused of illegally marketing its big-selling asthma drug Advair for use by mild asthma sufferers and the antidepressants Paxil and Wellbutrin for use by children and teenagers without approval from the US regulator the Food and Drug Administration (FDA). Several antidepressants have been associated with increased risk of suicide in younger patients.

Illinois attorney general, Lisa Madigan, said in a statement: “GlaxoSmithKline put its business interests ahead of what was best for vulnerable patients.”

While doctors are allowed to prescribe medicines as they see fit – including so called off-label uses – pharmaceutical companies are allowed to promote their products only for conditions specifically approved by the FDA.

#pharma

Dr. Drew Pinsky’s relationship with drugmaker raises ethical questions
►http://www.washingtonpost.com/lifestyle/style/dr-drew-pinskys-relationships-with-drug-makers-raise-ethics-questions/2012/07/06/gJQA8tHjSW_story.html?hpid=z4

Buried in a gargantuan Justice Department settlement announced this week with the pharmaceutical giant GlaxoSmithKline are details of a sweet deal Pinsky cut to promote the depression drug Wellbutrin, also known by the name Bupropion.

#pharma #conflits_d_intérêt

Glaxo Agrees to Pay $3 Billion in Fraud Settlement
►http://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html?_r=1&ref=g

The British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for illegally promoting the antidepressants Paxil and Wellbutrin and for failing to report safety data about the diabetes drug Avandia, federal prosecutors announced Monday.

#pharma